EGFR and non-small cell lung carcinoma: The overexpression of EGFR plays a key role in cellular proliferation, metastasis, apoptosis inhibition, and chemoradioresistance [1]; its targeting with tyrosine kinase inhibitors (TKIs) has improved survival in metastatic NSCLC patients [2].